Federal Register of Legislation - Australian Government

Skip to primary navigation Skip to primary content
Federal Register of Legislation Skip to Content
SearchOpen search

Primary content

Bookmark

this version | go to latest

Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine) Amendment (No. 1) Determination 2023

Authoritative Version
  • - F2023L00030
  • In force - Latest Version
Determinations/Health as made
This instrument amends the Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine) Determination 2021 to streamline and simplify the Medicare Benefits Schedule items used to assess a patient’s suitability for a COVID-19 vaccination.
Administered by: Health and Aged Care
Registered 11 Jan 2023
Table of contents.
Skip Navigation Links.

Commonwealth Coat of Arms of Australia

 

Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine) Amendment (No. 1) Determination 2023

I, Travis Haslam, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated               10 January 2023

Travis Haslam

Acting First Assistant Secretary

Medical Benefits Division

Health Resourcing Group

Department of Health and Aged Care

 

 

 

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1— Amendments.......................................................................................................... 2

 

 

 

1  Name

                        This instrument is the Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine) Amendment (No. 1) Determination 2023.

2  Commencement

(1)       Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 February 2023

 

                Note:        This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)       Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                        This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

4  Schedules

                        Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

 

 

 

 

 

Schedule 1— Amendments

Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID‑19 Vaccine) Determination 2021

1     Section 4 (Definition of a booster dose) 

Repeal the definition

2     Section 4 (Definition of a primary dose)

Repeal the definition

3     Section 9(1)

Omit “$68.40”, substitute “$139.00”.

4     Schedule (the table)

Repeal the table, substitute:

Group A44 – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine

Subgroup 3— Assessing Patient Suitability for a Dose of a COVID-19 Vaccine

Item

Service

Fee ($)

93644

Professional attendance by a general practitioner for the purpose of assessing a patient’s suitability for a COVID-19 vaccine if all of the following apply:
(a)  one or both of the following is undertaken, where clinically relevant:
    (i) a short patient history;
    (ii) limited examination and management;
(b)  the service is bulk-billed;
(c)  the service is provided at, or from, a practice location in a Modified Monash 1 area

 41.25

93645

Professional attendance by a general practitioner for the purpose of assessing a patient’s suitability for a COVID-19 vaccine if all of the following apply:
(a)  one or both of the following is undertaken, where clinically relevant:
    (i) a short patient history;
    (ii) limited examination and management;
(b)  the service is bulk-billed;
(c)  the service is provided at, or from, a practice location in:
    (i)  a Modified Monash 2 area; or
    (ii) a Modified Monash 3 area; or
    (iii) a Modified Monash 4 area; or
    (iv) a Modified Monash 5 area; or
    (v) a Modified Monash 6 area; or
    (vi) a Modified Monash 7 area

 

45.25

93646

Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient’s suitability for a COVID-19 vaccine if all of the following apply:
(a)  one or both of the following is undertaken, where clinically relevant:
    (i) a short patient history;
    (ii) limited examination and management;
(b)  the service is bulk-billed;
(c)  the service is provided at, or from, a practice location in a  Modified Monash 1 area

 

33.10

93647

Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient’s suitability for a COVID-19 vaccine if all of the following apply:
(a)  one or both of the following is undertaken, where clinically relevant:
     (i) a short patient history;
     (ii) limited examination and management;
(b)  the service is bulk-billed;
(c)  the service is provided at, or from, a practice location in:
      (i)  a Modified Monash 2 area; or
      (ii) a Modified Monash 3 area; or
      (iii) a Modified Monash 4 area; or
      (iv) a Modified Monash 5 area; or
      (v) a Modified Monash 6 area; or
      (vi) a Modified Monash 7 area

 

40.95

Subgroup 4— After-Hours Assessing Patient Suitability for a Dose of a COVID-19 Vaccine

93653

Professional attendance by a general practitioner for the purpose of assessing a patient’s suitability for a COVID-19 vaccine if all of the following apply:

(a)  one or both of the following is undertaken, where clinically relevant:

    (i) a short patient history;

     (ii) limited examination and management;

(b)  the service is bulk-billed;

(c)  the service is provided at, or from, a practice location in a Modified Monash 1 area;

(d)  the service is rendered in an after-hours period

55.95

93654

Professional attendance by a general practitioner for the purpose of assessing a patient’s suitability for a dose of a COVID-19 vaccine if all of the following apply:

(a)  one or both of the following is undertaken, where clinically relevant:

(i) a short patient history;

  (ii) limited examination and management;

(b)  the service is bulk-billed;

(c)  the service is provided at, or from, a practice location in:

(i)  a Modified Monash 2 area; or

(ii) a Modified Monash 3 area; or

(iii) a Modified Monash 4 area; or

(iv) a Modified Monash 5 area; or

(v) a Modified Monash 6 area; or

(vi) a Modified Monash 7 area;

(d)  the service is rendered in an after-hours period

59.90

93655

Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient’s suitability for a COVID-19 vaccine if all of the following apply:

(a)  one or both of the following is undertaken, where clinically relevant:

    (i) a short patient history;

    (ii) limited examination and management;

(b)  the service is bulk-billed;

(c)  the service is provided at, or from, a practice location in a Modified Monash 1 area;

(d)  the service is rendered in an after-hours period

45.10

93656

Professional attendance by a medical practitioner (other than a general practitioner) for the purpose of assessing a patient’s suitability for a COVID-19 vaccine if all of the following apply:

(a)  one or both of the following is undertaken, where clinically relevant:

(i) a short patient history;

  (ii) limited examination and management;

(b)  the service is bulk-billed;

(c)  the service is provided at, or from, a practice location in:

(i)  a Modified Monash 2 area; or

(ii) a Modified Monash 3 area; or

(iii) a Modified Monash 4 area; or

(iv) a Modified Monash 5 area; or

(v) a Modified Monash 6 area; or

(vi) a Modified Monash 7 area;

(d)  the service is rendered in an after-hours period

52.65

Subgroup 5 – In-depth Patient Assessment for a Patient who has Received a Vaccine Suitability

Assessment Service

10660

Professional attendance by a general practitioner, if all of the following apply:

(a)  the service is associated with a service to which item 93644, 93645, 93653 or 93654 applies;

(b)  the service requires personal attendance by the general practitioner, lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine;

(c)  one or both of the following is undertaken, where clinically relevant:

(i)     a detailed patient history;

(ii)   complex examination and management;

(d)  the service is bulk-billed

46.70

10661

Professional attendance by a medical practitioner (other than a general practitioner), if all of the following apply:

(a)  the service is associated with a service to which item 93646, 93647, 93655 or 93656 applies;

(b)  the service requires personal attendance by the medical practitioner (other than a general practitioner), lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine;

(c)  one or both of the following is undertaken, where clinically relevant:

    (i)     a detailed patient history;

    (ii)   complex examination and management;

(d)  the service is bulk-billed

37.40

Subgroup 6— Off-Site Patient Assessment on Behalf of a Medical Practitioner

93660

Attendance by a relevant health professional on behalf of a medical practitioner for the purpose of assessing a patient’s suitability for a dose of a COVID-19 vaccine if all of the following apply:

(a)  one or both of the following is undertaken, where clinically relevant:

     (i) a short patient history;

     (ii) limited examination and management;

(b)  the service is bulk-billed;

(c)  the service is not provided at a practice location; and

(d)  the service is provided from a practice location in a Modified Monash 1 area

 25.10

93661

Attendance by a relevant health professional on behalf of a medical practitioner for the purpose of assessing a patient’s suitability for a dose of a COVID-19 vaccine if all of the following apply:

(a)  one or both of the following is undertaken, where clinically relevant:

(i) a short patient history;

  (ii) limited examination and management;

(b)  the service is bulk-billed;

(c)  the service is not provided at a practice location; and

(d)  the service is provided from a practice location in:

(i)  a Modified Monash 2 area; or

(ii) a Modified Monash 3 area; or

(iii) a Modified Monash 4 area; or

(iv) a Modified Monash 5 area; or

(v) a Modified Monash 6 area; or

(vi) a Modified Monash 7 area

28.65